Mondelez InternationalvsMEDIFAST

MDLZ and MED stock compared: price, dividend, valuation and results, from SEC filings.

Mondelez International (MDLZ) has a market value of $85.3B and MEDIFAST (MED) $134M. Over the last year, with dividends, MDLZ moved +24.1% and MED +9.9%. Dividend yield: MDLZ 3.03%, MED 0.13%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MDLZ$85.3B

    MED$134M

    MDLZ is 636 times MED

  • Revenue, 12 months

    MDLZ$39.9B

    MED$300M

    MDLZ is 133 times MED

  • Net income, 12 months

    MDLZ$4.1B

    MED-$41M

  • Operating margin

    MDLZ13.7%

    MED-11.6%

    25.3 points apart

  • ROIC

    MDLZ9.1%

    MED-13.9%

    23.0 points apart

  • P/E

    MDLZ20.9

    MED–

  • Dividend yield

    MDLZ3.0%

    MED0.1%

    2.9 points apart

  • 5-year return

    MDLZ+22.6%

    MED-94.0%

    116.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MDLZ+22.7%

MED-94.0%

05010020222023202420252026
Returns by period
PeriodMDLZWith dividendsMEDWith dividends
1 year since November 17, 2025+24.1%Price +19.8%+9.9%Price +9.9%
3 years since November 17, 2023+3.1%+1.0% a yearPrice -5.7%-81.7%-43.2% a yearPrice -81.7%
5 years since November 17, 2021+22.6%+4.2% a yearPrice +7.1%-94.0%-43.1% a yearPrice -94.6%
10 years since November 18, 2016+97.4%+7.0% a yearPrice +55.1%-61.7%-9.1% a yearPrice -70.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MDLZMondelez InternationalMEDMEDIFAST

Valuation

MDLZMED
Valuation
Price$66.56$12.20
Market value$85.3B$134M
Enterprise value (EV)$104B–
P/E20.9–
P/E, 5-year median21.812.1
P/B3.20.7
EV/EBIT19.0–
Free cash flow yield4.3%–

Results and growth

MDLZMED
Results and growth
Revenue, 12 months$39.9B$300M
Net income, 12 months$4.1B-$41M
Free cash flow, 12 months$3.7B-$3.9M
Earnings per share, 12 months$3.18-$3.69
Revenue growth, year on year5.8%-36.0%
Revenue growth a year, past+7.7%over 5 years-16.2%over 5 years
EPS growth a year, past-5.2%over 5 years–

Margins and returns on capital

MDLZMED
Margins and returns on capital
Gross margin34.3%69.2%
Operating margin13.7%-11.6%
Net margin10.2%-13.6%
ROIC9.1%-13.9%
ROE15.6%-20.7%

Balance sheet

MDLZMED
Balance sheet
Cash$1.7B$172M
Total debt$20.6B$21M
Net debt / EBITDA2.7–
Interest cover9.2×–

Dividends and buybacks

MDLZMED
Dividends and buybacks
Dividend yield3.0%0.1%
Dividend per share, 12 months$2.02$0.02
Dividend growth a year, past+10.4%over 5 years–
Buyback yield2.8%–
Shareholder yield5.8%0.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MDLZ or MED

Didn't find what you were looking for?

Ask us
Which is bigger, Mondelez International or MEDIFAST?

By market value, Mondelez International ($85.3B) is about 636.3 times MEDIFAST ($134M), at today's prices.

How did MDLZ and MED stock do over the last 10 years?

Since November 18, 2016, MDLZ's price moved +55.1% and MED's -70.0%. With dividends: MDLZ +97.4% (+7.0% a year), MED -61.7% (-9.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, MDLZ or MED?

The dividend yield at today's price is 3.03% for Mondelez International and 0.13% for MEDIFAST. Over the last twelve months they paid $2.02 and $0.02 per share.

Which has the higher profit margins, Mondelez International or MEDIFAST?

Over the last twelve months, the net margin was 10.2% for Mondelez International and -13.6% for MEDIFAST, and the operating margin 13.7% and -11.6%. Revenue was $39.9B and $300M.

Which is the better investment, Mondelez International or MEDIFAST?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.